Shareholding disclosure

UBS AG

Declared position

6.6%

Threshold

Crossed upwards

Timeline

Published

27.02.2014

Transaction

19.02.2014

Transfer date

19.02.2014

Voting rights breakdown

Voting rights acquired6.6%

Voting rights sold1.97%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAE2Q00018

Beneficial owner

UBS AG

Declared address

UBS AG, 8098 Zürich

Aktueller Weblink: http://www.galenica.com/wAssetsGalenica/bin/shared/f52b5e449a2303c031a0c3a1109360bf/20140219_-_Galenica_AG_-_Beilage.pdf

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

UBS AG

Vifor Pharma AG27.02.2014TAE2Q00018

Disclosure summary

UBS AG disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 27.02.2014, at 6.6% of voting rights. Notice category: Single shareholder.

Disclosed position

6.6%

Voting rights acquired

Voting rights acquired6.6%

Voting rights sold1.97%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

UBS AG disclosed a holding in Vifor Pharma AG, published on 27.02.2014.

Publication date27.02.2014

Transaction date19.02.2014

Transfer date19.02.2014

Issuing companyVifor Pharma AG

Beneficial ownerUBS AG

Declared addressUBS AG, 8098 Zürich

CategorySingle shareholder

Voting rights acquired6.6%

Voting rights sold1.97%

Below threshold0%

ExchangeXSWX

Notification IDTAE2Q00018

Commercial register

CHE-101.329.561

Registered

Zefix record

Conditions

Aktueller Weblink: http://www.galenica.com/wAssetsGalenica/bin/shared/f52b5e449a2303c031a0c3a1109360bf/20140219_-_Galenica_AG_-_Beilage.pdf

Source: SIX Exchange Regulation · Publication date: 27.02.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open